Raltegravir pharmacokinetics during pregnancy. (Q34422111)

2 August 2017

Raltegravir pharmacokinetics during pregnancy. (English)

1 reference

2 August 2017

1 reference

1 reference

9

Regis Kreitchmann

1 reference

2 August 2017

13

Elizabeth Smith

1 reference

2 August 2017

1

D Heather Watts

1 reference

2 August 2017

5

Edmund V Capparelli

1 reference

2 August 2017

Alice Stek

2

1 reference

2 August 2017

Brookie M Best

3

1 reference

2 August 2017

Jiajia Wang

4

1 reference

2 August 2017

Tim R Cressey

6

1 reference

2 August 2017

Francesca Aweeka

7

1 reference

2 August 2017

Patty Lizak

8

1 reference

2 August 2017

Sandra K Burchett

10

1 reference

2 August 2017

David E Shapiro

11

1 reference

2 August 2017

Elizabeth Hawkins

12

1 reference

2 August 2017

Mark Mirochnick

14

1 reference

2 August 2017

IMPAACT 1026s study team

15

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 December 2014

1 reference

Journal of Acquired Immune Deficiency Syndromes

2 August 2017

1 reference

2 August 2017

67

1 reference

2 August 2017

375-381

1 reference

2 August 2017

4

1 reference

Three distinct phases of HIV-1 RNA decay in treatment-naive patients receiving raltegravir-based antiretroviral therapy: ACTG A5248

2 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4213295

Increase in transaminase levels following the use of raltegravir in a woman with a high HIV viral load at 35 weeks of pregnancy

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4213295

Raltegravir pharmacokinetics in treatment-naive patients is not influenced by race: results from the raltegravir early therapy in African-Americans living with HIV (REAL) study

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4213295

Rapid decline in HIV viral load when introducing raltegravir-containing antiretroviral treatment late in pregnancy

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4213295

Use of newer antiretroviral agents, darunavir and etravirine with or without raltegravir, in pregnancy: a report of two cases

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4213295

Minimal effects of ritonavir and efavirenz on the pharmacokinetics of raltegravir

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4213295

Raltegravir once daily or twice daily in previously untreated patients with HIV-1: a randomised, active-controlled, phase 3 non-inferiority trial.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4213295

High neonatal concentrations of raltegravir following transplacental transfer in HIV-1 positive pregnant women

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4213295

Rapid HIV-RNA decline following addition of raltegravir and tenofovir to ongoing highly active antiretroviral therapy in a woman presenting with high-level HIV viraemia at week 38 of pregnancy

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4213295

Atazanavir modestly increases plasma levels of raltegravir in healthy subjects

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4213295

Reduced lopinavir exposure during pregnancy

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4213295

Pharmacokinetic and safety of raltegravir in pregnancy

27 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25162818

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1097/QAI.0000000000000318

1 reference

2 August 2017

1 reference

2 August 2017

1 reference